CompletedNot Applicable

A Study to Evaluate Effectiveness and Safety of Hyaluronic Acid (HA) Fillers

Germany, Italy, United Kingdom90 participantsStarted 2018-11-09

Plain-language summary

The purpose of the study is to investigate the degree of improvement in appearance after treatment with different hyaluronic acid (HA) fillers. Product selection is based on Investigator assessment of participant tissue coverage and main treatment goal (volumizing, lifting or contouring).

Who can participate

Age range25 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male/Female 25 to 55 years old that needs lifting, contouring or volumization of the midface * Signed and dated informed consent Exclusion Criteria: * Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel and lidocain * Previous use of any permanent or semi-permanent facial tissue augmentation therapy or contouring with, lifting threads, permanent implants, or autologous fat in the treatment area * Previous use of any HA or collagen based facial tissue augmentation therapy in the facial area, any previous use of neurotoxin or any previous facial surgery * Any medical condition that in the opinion of the Investigator would make the participant unsuitable for inclusion

What they're measuring

Percentage of Participants With Aesthetic Improvement of Midface

Timeframe: 8 weeks

Trial details

NCT IDNCT03869450

SponsorGalderma R&D

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2019-08-30

Results submitted2020-03-17

View on ClinicalTrials.gov More Volume Deficiency of the Midface trials